The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Related News Articles

Headline
The American Heart Association released a study Oct. 28 that found disruptions to people’s circadian rhythm can increase their risk of cardiovascular disease…
Headline
There have been 1,596 confirmed cases of measles across the U.S. this year, according to the latest data from the Centers for Disease Control and Prevention.…
Headline
Measles cases have been reported by 42 states and jurisdictions this year, with 1,563 total nationwide, according to the latest data released yesterday by the…
Headline
A JAMA study published yesterday analyzed the health characteristics of individuals projected to lose Medicaid coverage due to work requirements included in…
Headline
The Department of Health and Human Services announced Sept. 30 that it is doubling its funding for childhood cancer research from $50 million to $100 million…
Headline
The White House Sept. 9 released its “Make Our Children Healthy Again” strategy report, created to address childhood chronic diseases. The report highlights…